• English
    • Română(Romanian)
  • Company
    • Presentation
    • Recognition and awards
    • CEO’s Message
    • Mission and values
    • Quality
      • Quality Policy
      • Certifications
      • Integrated Management System
      • Contract manufacturing
    • History
  • Investors
    • Information for shareholders
      • Events Calendar
      • Shareholder Structure
      • Stock Quotes
      • Dividends handout
      • Meeting with investors
      • Presentations
      • Events
      • Analist coverage
    • The General Meeting of Shareholders
      • Procedures of the General Meeting of Shareholders
      • Archive of The General Meeting of Shareholders
    • Management’s transactions
    • Affiliated persons’ transactions
    • Financial information
      • Financial reporting
      • Annual reports
    • News release and current reports
    • Contact for Investor Relations
  • Corporate Governance
    • Reference documents
    • Governance structure
    • Transparency. Reporting obligations
    • Governance documents
    • Reports
    • Social responsability
    • National anti-corruption strategy
    • Whistleblowers in the Public Interest
    • Administrator selection procedure 2024
    • General Manager Selection Procedure 2025
  • Development
    • Research
    • Regulatory Affairs
    • Biotechnologies
    • Centre for Drug Evaluation
      • Services
      • Studies
      • Clinical trials
      • Selecting volunteers
  • Products
    • Medicines for human use
      • Over the counter drugs
      • Nutriensa
      • Cosmetic products
      • Medicines with prescription
      • Medical devices
    • Veterinary products
      • Prescription veterinary products
      • Veterinary products > VetAria+ range
    • VetAria+
    • Active pharmaceutical ingredients
    • Pharmacovigilance
  • Partners
    • Local Partners
    • Foreign partners
    • Nystatin
    • Finished products
    • Antibiotice in the world
  • Media
    • News
    • Media Relation Contact
    • Press Releases
    • Public Interest Announcements
      • Processing personal data
    • European and National Funding Projects
      • Development and innovation in health
      • Education and practical training
      • Sustainability and energy efficiency
  • Careers
    • a+ Academy
    • Open Positions
    • Benefits and development
  • Sustainability
    • ESG Reports
    • ESG Policies
      • Environmental
      • Social
      • Governance
    • Responsible for future generations
    • “Science and Soul” Foundation
    • ESG Assessments and Ratings
      • 2026 Results
      • 2025 Results
      • 2024 Results
      • 2023 Results
    • Affiliations
  • Online orders
  • Contact
    • Company Info
      • Social responsability real
    • How to contact us
    • Complains
    • Side effects from Saudi Arabia
Home > Media > News > News archive

Yearly Archives: 2023

Antibiotice Iasi maintained the growth trend of turnover and profitability in the first 9 months of 2023

First InvestEU agreement in Romania provides €25 million in EIB financing to boost security of supply for medicines

Antibiotice announces the selection of the European Investment Bank to finance investment projects worth EUR 25 million

Multiplying the export of Antibiotice Iasi 9 times in the last twenty years. We create the future together with our partners!

Multiplying the export of Antibiotice Iași nine times in the last 20 years. We build the future together with our partners!

Antibiotice takes an important step towards sustainable development and becomes a member of the Sustainable Romania Coalition

A new GLP certification obtained by the Clinical Studies Center (CSC) @ Antibiotice Iași

A new auction won by Antibiotice in the UK

Antibiotice attracts funds from PNRR for green energy production

Financing for a new investment in production and research capacity

Financing for a new investment in production and research capacity

The European Investment Bank and Antibiotice signed an advisory service agreement for the strategic development of the industrial site of the company


Copyright 2026 Antibiotice SA
Toate drepturile rezervate.
  • Company
  • Investors
  • Corporate Governance
  • Development
  • Products
  • Partners
  • Media
  • Careers
  • Sustainability
  • Contact
  • Terms and conditions of use
  • Cookie Policy
  • Processing personal data

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

  • English
  • Română (Romanian)
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Cookie Policy

More information about our Cookie Policy